Validation of the Safer Opioid Prescribing Evaluation Tool (SOPET) for Assessing Adherence to the Centers for Disease Control Opioid Prescribing Guidelines.
Validation of the Safer Opioid Prescribing Evaluation Tool (SOPET) for Assessing Adherence to the Centers for Disease Control Opioid Prescribing Guidelines.
复制标题
验证更安全的阿片类药物处方评估工具 (SOPET)，用于评估疾病控制中心阿片类药物处方指南的遵守情况。
DOI：
10.1093/pm/pnaa138
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Robinson-Papp,Jessica
中科院分区：
文献类型：
--
作者：
Navis,Allison;George,Mary-Catherine;Nmashie,Alexandra;Hoang,Ethan;Cedillo,Gabriela;Robinson-Papp,Jessica
目的针对阿片类药物的流行，美国疾病控制和预防中心于2016年发布了治疗慢性疼痛的阿片类药物处方指南(CDCG)。为了便于研究CDCG的实施是否会导致阿片类药物处方的减少和患者安全性的提高，我们试图验证一种基于临床文献的量化CDCG依从性的工具。设计安全的阿片类药物预描述评估工具(SOPET)分四个阶段开发，作为改进CDCG在临床环境中实施的研究的一部分。四名具有不同临床经验和专业知识水平的评分员接受了使用SOPET的培训，然后使用它评估了21次基线患者会面。根据平均评分(k = 4)、绝对一致、双向随机效应模型，计算组内相关系数估计值及其95%可信区间。结果评分者间信度较好，平均测量系数为0.82(95%CI=0.63~0.92)。3名MD评分者的内部信度良好，平均ICC分别为0.92(95%CI=0.81~0.97)、0.97(95%CI=0.92~0.99)、0.99(95%CI=0.99~0.99)。然而，非MD评定者的内部信度为0.69(95%CI=0.22-0.88)。结论总体来说，SOPET对临床文献中CDCG的实施情况进行评估是有用的。这是未来评估坚持CDCG是否能改善患者安全结果的研究设计的重要第一步。
ObjectiveIn response to the opioid epidemic, the Centers for Disease Control and Prevention issued guidelines (CDCG) in 2016 for the prescription of opioids for chronic pain. To facilitate research into whether CDCG implementation will lead to reductions in opioid prescribing and improved patient safety, we sought to validate a tool that quantifies CDCG adherence based on clinical documentation.DesignThe Safe Opioid Prescribing Evaluation Tool (SOPET) was developed in four phases as part of a study to improve the implementation of the CDCG in the clinical setting. Four raters with varying levels of clinical experience and expertise were trained to use the SOPET and then used it to evaluate 21 baseline patient encounters. Intraclass correlation coefficient (ICC) estimates and their 95% confident intervals (CIs) were calculated for the total SOPET score based on a mean-rating (k = 4), absolute-agreement, two-way random-effects model. For intrarater reliability, two-way mixed-effect models were used.ResultsInter-rater reliability was good, with an average-measures ICC of 0.82 (95% CI = 0.63–0.92). Intrarater reliability was excellent for the three raters, who were MDs, with average-measures ICCs as follows: 0.92 (95% CI = 0.81–0.97), 0.97 (95% CI = 0.92–0.99), 0.99 (95% CI = 0.99–0.99). However, the intrarater reliability for the non-MD rater was lower 0.69 (95% CI = 0.22–0.88).ConclusionsOverall, the SOPET is useful for evaluating implementation of the CDCG in clinical documentation. It is an important first step in the design of future studies assessing whether adherence to the CDCG improves patient safety outcomes.
登录
查看更多内容
影响因子：
3.1
作者：
Sekhon, Ripple;Aminjavahery, Noushin;Robinette, Camille
通讯作者：
Robinette, Camille
社区设计中心（CDC）
DOI：
--
发表时间：
--
期刊：
影响因子：
--
作者：
通讯作者：
--
DOI：
10.3122/jabfm.2019.04.180296
发表时间：
2019-07-01
影响因子：
2.9
作者：
Arizmendez, Natalia P.;Kotovicz, Fabiana;Baumgardner, Dennis J.
通讯作者：
Baumgardner, Dennis J.
影响因子：
158.5
作者：
Dart, Richard C.;Surratt, Hilary L.;Green, Jody L.
通讯作者：
Green, Jody L.
DOI：
10.1016/j.mayocpiqo.2018.09.004
发表时间：
2018-12-01
期刊：
Mayo Clinic proceedings. Innovations, quality & outcomes
影响因子：
--
作者：
Witt, Terrence J;Deyo-Svendsen, Mark E;Abu Dabrh, Abd Moain
通讯作者：
Abu Dabrh, Abd Moain